Table 1.
Characteristics of included studies.
| Study | Published Year | Design | Type of vascular invasion | Case | Median Survival time | |||
|---|---|---|---|---|---|---|---|---|
| Total | Hepatectomy | TACE | Hepatectomy (months) |
TACE (months) |
||||
| Po-Hong Liu | 2014 | Case-matched | PVTT | 216 | 108 | 108 | 64 | 32 |
| Jia-Ye Zhou | 2014 | Cohort Study | PVTT | 176 | 90 | 86 | 8.2 | 7 |
| Qi Zhou | 2011 | Cohort Study | PVTT | 48 | 38 | 10 | 10 | 7 |
| Yong-Fa Zhang | 2015 | Case-matched | HVTT | 84 | 28 | 56 | 15.6 | 9.1 |
| Zhen-Wei Peng | 2012 | Case-matched | PVTT | 603 | 201 | 402 | 20.0±1.8 | 13.1±0.6 |
| Yi Wang | 2013 | Cohort Study | IVC/RA | 45 | 25 | 20 | 19 | 4.5 |
| Shu-Qun Cheng | 2005 | Cohort Study | PVTT | 45 | 7 | 38 | 8.0 | 5.0 |
| Liang Ma | 2013 | Cohort Study | PVTT | 176 | 90 | 86 | 8.2 | 7.0 |
| Zhi-Ming Wang | 2015 | Cohort Study | PVTT | 335 | 273 | 62 | 4.65 | 5.65 |
PVTT: Portal vein tumor thrombosis; HVTT: Hepatic vein tumor thrombosis; IVC: inferior vena cave; AR: right atrium.